Swiss Tropical & Public Health Institute
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Private
- Established
- 1943-01-01
- Employees
- 501
- Market Cap
- -
- Website
- https://www.swisstph.ch
Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania
Phase 1
Completed
- Conditions
- Falciparum Malaria
- Interventions
- Biological: PEV 301& 302 in virosomesBiological: Inflexal V (active comparator)
- First Posted Date
- 2007-08-09
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Swiss Tropical & Public Health Institute
- Target Recruit Count
- 50
- Registration Number
- NCT00513669
- Locations
- 🇹🇿
Bagamoyo Research and Training Unit, Bagamoyo, Tanzania
Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides
Phase 1
Terminated
- Conditions
- Falciparum Malaria
- First Posted Date
- 2006-11-16
- Last Posted Date
- 2006-11-16
- Lead Sponsor
- Swiss Tropical & Public Health Institute
- Target Recruit Count
- 46
- Registration Number
- NCT00400101
The Community Effectiveness of IPTi in Southern Tanzania
Phase 3
- Conditions
- Malaria, FalciparumAnemia
- Interventions
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2008-05-22
- Lead Sponsor
- Swiss Tropical & Public Health Institute
- Target Recruit Count
- 13000
- Registration Number
- NCT00152204
- Locations
- 🇹🇿
Ifakara Health Research & Development Centre, Dar es Salaam, Tanzania
© Copyright 2025. All Rights Reserved by MedPath